Team

She is a Fellow of the Judge Business School of the University of Cambridge and a member of the Investment Committee of Cambridge Enterprise. Pam is Chair of Cambridge Angels and sits on the board of Albion Crown Venture Capital Trust. She founded and co-chairs The Cambridge Health Network, a membership group of senior players in the UK health sector. Pam advises a number of life science companies, health technology accelerators and start-ups in the UK and Europe.

She has held academic leadership roles at institutions worldwide and undertaken degrees across several countries, allowing her to become very familiar with different education and health systems. She holds a doctorate from the University of Oxford. Nora also serves on the Industrial Advisory Board for Prince Sultan University in Saudi Arabia, Reform, Health Council UK (an independent think tank), Emlyon Business School, Healthcare Innovation, Technology & Society Institute, Scientific Committee, and Bedfordshire NHS Trust Governor.

Bracy founded an early-stage biotech company during her research career, focused on novel therapeutics for heart failure. She subsequently worked in investment banking, leading the healthcare practice of a London-based boutique investment and advisory firm. In 2024, Bracy moved to the operating side of the table, joining Caresyntax, a growth stage surgical technology company, as VP Strategy and Corporate Development. She also invests in healthcare technology and MedTech via a private family office, where she is Head of Platform and a member of the Investment Committee.

As Minister, Robert launched the Skills for Life campaign to encourage more employers to take on apprentices, and brought through the Lifelong Learning Entitlement to transform Adult learning. In 2017, he was elected as Chair of the House of Commons Education Select Committee (and re-elected in 2019). Previously held roles and recognitions include Deputy Chairman of the Conservative Party (2015 to 2016), PPS to the Chancellor of the Exchequer, Rt Hon George Osborne MP (2014 to 2015), Lifetime Privy Counsellor using the title Rt Hon, Minister of the Year 2024, Spectator Backbencher of the Year 2022, AAC Special Recognition Award 2018 and Spectator Campaigner of the Year 2013.

As former Chairman of the Management Board of Landesbank Baden-Württemberg, Siegfried has vast expertise within financial services. Before joining Augur, Siegfried was a Board Member and partner of MainFirst Bank AG. Siegfried has also been president of the Federal Association of Public Banks, Chairman of the Baden-Württembergische Stock Exchange Stuttgart, member of the BaFin and CEBS Advisory Board, Supervisory Board Member of KfW and chairman of the Supervisory Board at Heidelberger Druckmaschinen. Siegfried has a degree in business administration at the University Cologne and obtained his doctorate in history and philosophy from the University Düsseldorf.

Sneh has been the Global Medical Director for Bupa, Head of Population Health at Aetna/CVS Health, the US healthcare giant, and CEO of the Simplyhealth Group, a £240M revenue health insurer in the UK. Currently he is Venture Partner at Archimed Health and Executive Director at NEOM in Saudi Arabia, looking after Health & Wellbeing for the mega-project. He chairs or sits on the boards of a range of companies, including Synnovis, the UK largest laboratory/pathology provider, Habitual Healthcare, AllergyRhino,  Medi2Data, Qured and Vault Capital Advisors. Sneh is an Honorary Professor of Healthcare at the University of Wales and holds an honorary degree in Public Health. He was made a CBE in the King’s New Years honours in 2025.

He is founding CEO of Cognitant Group, a health technology company creating clinically-led immersive experiences using virtual reality, augmented reality and interactive mobile content. His past executive experience includes being CEO of M3 EU, also a health technology company providing physicians with trusted services and communities in which they can connect with each other and with healthcare organisations. Tim is also an adviser to health tech companies having worked over the years with innovators such as Qured and eConsult. He has served as president of the Digital Health council at the Royal Society of Medicine and is a Fellow of the NHS innovation accelerator.

Previous to this he was an Officer and Vice-President at Genentech based in San Francisco leading a team of over 500 people across US Medical Affairs. He moved to this role after four years as Country Medical Director of Roche UK leading teams across all therapy areas. Previous to this he has held both commercial and medical roles at a European and affiliate level. Rav studied medicine at St Mary’s Hospital Medical School at Imperial College, London, he is a Fellow of the Faculty of Pharmaceutical Medicine, a William Pitt Fellow at Pembroke College, Cambridge and holds an Executive MBA from Judge Business School, Cambridge.

Founding an international healthcare consulting business, which was later acquired by Healthsouth, she co-founded Vision Group—which became an ASX-listed Ophthalmic Doctor equity model. She has founded and lead several healthcare companies which have either been sold or listed on the ASX and has worked on many international mergers and acquisitions with private equity companies in the UK, Australia and the USA. Currently she co-owns Sydney Breast Clinic and holds existing board positions at Magentus, Ellerston JAADE Australian Private Assets Fund, Mable Technologies, Pharm X and Prospection. Jayne also serves as a Non-Executive Director at Pinnacle Charitable Foundation Prospection and an advisor to the Board of Problem Shared (UK based).